Updated: Minute Insight: FDA Clears Zimmer Biomet’s Identity Shoulder, ZB Calls It ‘Biggest Shoulder Launch In the Last Five Years’
Zimmer Biomet said on 20 September that the FDA cleared its Identity shoulder system and expects it to be available to US surgeons in the fourth quarter.
You may also be interested in...
In this first of two roundups, Medtech Insight highlights new product launches and technologies showcased at the annual AAOS conference by three major orthopedics players and medical data company Canary Medical.
Minute Insight: Abbott Wins Expanded FDA Approval For Proclaim XR Spinal Cord Stimulator For Diabetic Peripheral Neuropathy
Abbott said a major competitive benefit of the Proclaim XR SCS system is the battery life of up to 10 years at low settings.
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb provides highlights from the recent CES 2023 conference in Las Vegas. Reed Miller discusses Abbott’s VR partnership with the Blood Centers for America and Barnaby Pickering highlights Bayer’s jump into medtech with its buyout of Blackford Analysis.